2014
DOI: 10.1016/j.ejphar.2014.01.020
|View full text |Cite
|
Sign up to set email alerts
|

Valproic acid inhibits excess dopamine release in response to a fear-conditioned stimulus in the basolateral complex of the amygdala of methamphetamine-sensitized rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
9
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 18 publications
0
9
0
Order By: Relevance
“…VPA has antiglutamatergic and N-methyl-D-aspartic acid (NMDA) receptor antagonistic activity. 2,3 It potentiates GABA effects, induces expression of melatonin receptor, 4 and decreases dopamine in the striatum 5 and basolateral complex of amygdala 6 while increasing dopaminergic activity in the hippocampal and prefrontal areas. 7 In addition, VPA increases acetylcholine efflux in rat hippocampus.…”
mentioning
confidence: 99%
“…VPA has antiglutamatergic and N-methyl-D-aspartic acid (NMDA) receptor antagonistic activity. 2,3 It potentiates GABA effects, induces expression of melatonin receptor, 4 and decreases dopamine in the striatum 5 and basolateral complex of amygdala 6 while increasing dopaminergic activity in the hippocampal and prefrontal areas. 7 In addition, VPA increases acetylcholine efflux in rat hippocampus.…”
mentioning
confidence: 99%
“…21 Although glutamate antagonism in the inferior colliculus attenuated hyperactive startle response in rats, 22 studies with NMDA ( N -methyl- d -aspartate) antagonist such as memantine did not change startle magnitude in humans. 23,24 Hence, decreased ASR rates and increased latencies of ASRs and SSSs in our study may be attributed to dopaminergic or serotoninergic antagonism or GABA agonistic effect.…”
Section: Discussionmentioning
confidence: 51%
“…21 Although glutamate antagonism in the inferior colliculus attenuated hyperactive startle response in rats, 22 studies with NMDA (N-methyl-d-aspartate) antagonist such as memantine did not change startle magnitude in humans. 23,24 Hence, decreased ASR rates and increased latencies of ASRs and SSSs in our study may be attributed to dopaminergic or serotoninergic antagonism or GABA agonistic effect. VPA inhibits spontaneous dopamine release and attenuates dopaminergic signaling with chronic treatment 24,25 whereas it potentiates the postsynaptic inhibition created by GABA even after acute infusion.…”
Section: Discussionmentioning
confidence: 57%
See 1 more Smart Citation
“…This was attributed to the transcriptional effects of VPA resulting in downregulation of the aromatic Lamino acid decarboxylase (AADC), which in turn decreased the decarboxylation of DOPA into dopamine. In a study on the effect of VPA on a trait marker of vulnerability to emotional stress in psychosis, which was represented by excess dopamine release in response to a fearconditioned stimulus (CS) in the basolateral complex of the amygdala of methamphetaminesensitized rats, VPA treatment decreased DA baseline levels as well as attenuated the excess of DA release in response to the CS in the amygdala of methamphetamine-sensitized rats (27).…”
Section: Dopamine (Da)mentioning
confidence: 99%